EX-10 9 filename9.htm BELLICUM PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • May 5th, 2020 • Texas
Contract Type FiledMay 5th, 2020 JurisdictionThis EMPLOYMENT AGREEMENT (this “Agreement”), made effective as of November 28, 2011 (the “Effective Date”), is by and between Bellicum Pharmaceuticals, Inc. a Delaware corporation (the “Company”), having an office at 6400 Fannin Street, Suite 2300, Houston, Texas 77030 and David M. Spencer, Ph.D., an individual, residing at 2811 Prescott St., Houston, Texas 77025 (“Executive”). The Company and Executive are referred to herein individually as a “Party” and collectively as the “Parties”. As used herein, “Affiliate” means any entity that directly or indirectly controls, is controlled by, or is under common control with, the Company.
BELLICUM PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • November 18th, 2014 • Bellicum Pharmaceuticals, Inc • Pharmaceutical preparations • Texas
Contract Type FiledNovember 18th, 2014 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (this “Agreement”), made effective as of October 17, 2011 (the “Effective Date”), is by and between Bellicum Pharmaceuticals, Inc. a Delaware corporation (the “Company”), having an office at 6400 Fannin Street, Suite 2300, Houston, Texas 77030 (“Company Premises”) and Annemarie Moseley, M.D., Ph.D., an individual, residing at 7913 Brightman Lane, Austin, Texas 78733 (“Executive”). The Company and Executive are referred to herein individually as a “Party” and collectively as the “Parties”. As used herein, “Affiliate” means any entity that directly or indirectly controls, is controlled by, or is under common control with, the Company.
BELLICUM PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • October 17th, 2014 • Bellicum Pharmaceuticals, Inc • Pharmaceutical preparations • Texas
Contract Type FiledOctober 17th, 2014 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (this “Agreement”), made effective as of November 28, 2011 (the “Effective Date”), is by and between Bellicum Pharmaceuticals, Inc. a Delaware corporation (the “Company”), having an office at 6400 Fannin Street, Suite 2300, Houston, Texas 77030 and David M. Spencer, Ph.D., an individual, residing at 2811 Prescott St., Houston, Texas 77025 (“Executive”). The Company and Executive are referred to herein individually as a “Party” and collectively as the “Parties”. As used herein, “Affiliate” means any entity that directly or indirectly controls, is controlled by, or is under common control with, the Company.
BELLICUM PHARMACEUTICALS, INC. SECOND AMENDED & RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • October 17th, 2014 • Bellicum Pharmaceuticals, Inc • Pharmaceutical preparations • Texas
Contract Type FiledOctober 17th, 2014 Company Industry JurisdictionThis SECOND AMENDED & RESTATED EMPLOYMENT AGREEMENT, dated as of November 9, 2011, is by and between Bellicum Pharmaceuticals, Inc. a Delaware corporation (the “Company”), having an office at 6400 Fannin Street, Suite 2300, Houston, Texas 77030 (“Company Premises”) and Thomas J. Farrell, an individual, residing at 910 Barton Creek Blvd, Austin, Texas 78746 (“Executive”).